Clinical Research Directory
Browse clinical research sites, groups, and studies.
Artificial Intelligence Support for Stroke
Sponsor: Capital Medical University
Summary
This study investigates whether an AI-assisted decision support tool, compared with standard care, increases the proportion of acute ischemic stroke patients receiving intravenous thrombolysis within 24 hours of symptom onset at a primary hospital in China, while also evaluating its impact on clinical outcomes, treatment timelines, and safety.
Official title: Artificial Intelligence-Assisted Decision Support for Intravenous Thrombolysis in Acute Ischemic Stroke at Basic Hospitals in China (ASSIST)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
516
Start Date
2026-09-01
Completion Date
2027-03-31
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Interventions
AI-assisted thrombolysis decision support
The AI-assisted thrombolysis decision support tool is used by attending physicians in addition to routine stroke evaluation. After the physician enters key patient data, the system generates real-time prompts on whether the patient meets criteria for intravenous thrombolysis, recommended additional tests and risk alerts for thrombolysis. The final treatment decision remains with the treating clinician.
Locations (1)
Liuyang Jili Hospital
Changsha, Hunan, China